Amrik Singh is an Immunology Fellow at Cell Signaling Technology. He is a biochemist trained at Boston University Medical Center and Beth Israel Deaconess Medical Center. At CST, he is helping to develop and manage the adoptive cell therapy product portfolio with a specific interest in developing antibodies and assays to characterize CAR-T cells.
